Home » Newsletters » BioWorld Science

BioWorld Science

April 27, 2012

View Archived Issues

Studies assess GS-9620-induced INF-alpha response and antiviral effects

Soligenix reports thermostability of vaccines using ThermoVax

U.S. university patents new candidate vaccine adjuvants

Novel potential vaccines reported for enteroviral infections

Phase I trial studies vandetanib combination therapy for brain cancer

Scientists in Europe uncover new recognition factor for HIV-1 entry

Phase I data available on antisense drug for ALS

IntelGenx and Redhill Biopharma launch pivotal trial of antimigraine product

Epizyme forms strategic partnership with Celgene

Shire reports topline data on drug for binge eating disorder

Galenea to receive funds from the Stanley Medical Research Institute

Phase I trial tests once-daily and intermittent INK-128 dosing

Continuation recommended for trial assessing whipworm egg therapy for Crohn's disease

Mount Sinai School of Medicine evaluates IGF-1 product in autism subtype

Omthera Pharmaceuticals reports topline results from EVOLVE study

Advanced Cell Technology clear to continue Stargardt's macular dystrophy trials

GlaxoSmithKline files application in Japan for ofatumumab

Novartis extends oncology discovery research collaboration

Dynavax files BLA for hepatitis B vaccine

FDA revises Victrelis label

Jazz Pharmaceuticals enters acquisition agreement

Amgen gives update on Xgeva sBLA

Investigation at Bionature yields novel candidate oncolytics

Novel DUB/FAF-X inhibitors presented

InterMune designs novel HCV NS3/NS4A inhibitors

German university announces novel candidate analgesics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...